Goldman Sachs
IDXX icon

Goldman Sachs’s Idexx Laboratories IDXX Stock Holding History

Goldman Sachs’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-32,000
Closed -$2.05M – 7385
2015
Q2 		$2.05M Buy
+32,000
New +$2.22M ﹤0.01% 3805
2013
Q4 		– Sell
-4,600
Closed -$229K – 6715
2013
Q3 		$229K Buy
+4,600
New +$221K ﹤0.01% 5759

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs's IDXX Position: Q1 2026 in Review

Goldman Sachs reduced its Idexx Laboratories (IDXX) stake by 14% in Q1 2026, selling an estimated $73.9M and leaving 716,921 shares worth $403M. The position accounts for 0.05% of the portfolio, ranked #407.

Goldman Sachs first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $563M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Goldman Sachs held 716,921 shares of Idexx Laboratories worth $403M as of Q1 2026.
  • Goldman Sachs sold 115,268 Idexx Laboratories shares in Q1 2026, an estimated $73.9M.
  • Idexx Laboratories made up 0.05% of Goldman Sachs's portfolio in Q1 2026, its #407 holding.
  • Goldman Sachs first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Idexx Laboratories position peaked at $563M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.